The World Health Organization (WHO) has officially certified Denmark for the elimination of mother-to-child transmission (EMTCT) of both HIV and syphilis, marking a historic achievement in the realm of global public health. This validation establishes Denmark as the first country within the European Union to reach this rigorous benchmark, signaling a major victory for the nation’s universal healthcare system and its long-standing commitment to maternal and neonatal welfare. The certification recognizes Denmark’s success in ensuring that vertical transmission—the passage of a pathogen from mother to baby during pregnancy, delivery, or breastfeeding—has been effectively neutralized through systematic screening, early intervention, and high-quality clinical care.
The elimination of mother-to-child transmission of HIV and syphilis marks a major public health achievement for Denmark, stated Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, during the announcement. According to Dr. Tedros, this milestone demonstrates that with strong political commitment and consistent investment in primary care and integrated maternal and child health services, countries can protect every pregnant woman and newborn from these diseases. The certification follows an exhaustive evaluation process that scrutinized Denmark’s health data, laboratory capacities, and clinical outcomes over several years, concluding that the nation has maintained the necessary thresholds to be considered free of these transmission routes.
The Path to Validation: A Rigorous Assessment Process
The path to this certification was governed by a strict set of global criteria established by the WHO to ensure that "elimination" is not merely a temporary dip in infection rates but a sustained public health reality. The validation process for Denmark reached its final stages in 2025. It began with a comprehensive assessment by the WHO’s Regional Validation Committee in June 2025, followed by a final review by the Global Validation Advisory Committee (GVAC) in August 2025.
To receive this status, Denmark had to prove that it met all required targets consistently from 2021 through 2024. These benchmarks are notoriously difficult to achieve and maintain. The WHO requires that a country provide prenatal testing and treatment to at least 95% of all pregnant women. Furthermore, the rate of new infant infections must be kept below 50 per 100,000 live births for at least two consecutive years. Denmark’s ability to exceed these metrics is a result of a highly organized national health infrastructure that prioritizes early detection and immediate therapeutic response.
Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, emphasized the significance of Denmark’s leadership within the European context. "As the first European Union country to achieve this public health milestone, Denmark’s success is a testament to the strength of its maternal health system and its long-standing commitment to reaching every pregnant woman with the care she needs," Dr. Kluge noted. He further explained that Denmark’s success is rooted in "strong antenatal care, reliable data systems, and respect for women’s rights."
Decades of Public Health Strategy and Infrastructure
Denmark’s achievement did not happen overnight; it is the culmination of decades of evolving public health policy. Since the emergence of the HIV/AIDS epidemic in the 1980s, Denmark has been at the forefront of implementing rights-based health strategies. The country’s approach has focused on de-stigmatizing testing and ensuring that medical care is a universal right rather than a privilege.
Central to this success is the Danish universal healthcare system, which provides free access to medical services for all residents. This "equal access" model ensures that socioeconomic status does not become a barrier to prenatal care. Pregnant women in Denmark are integrated into a streamlined "care pathway" that includes routine screening for HIV, syphilis, and hepatitis B at their first antenatal visit. If a woman tests positive, the system triggers a multidisciplinary response involving infectious disease specialists, obstetricians, and midwives to ensure she receives antiretroviral therapy (ART) or appropriate antibiotics to prevent transmission to the fetus.
The country’s exemplary data systems, specifically the Civil Registration System (CPR) and various national health registries, allow health authorities to track every pregnancy and birth outcome with precision. This robust laboratory capacity ensures that testing is not only frequent but also highly accurate, allowing for rapid intervention. Moreover, the Danish model emphasizes the autonomy and rights of the patient, ensuring that screening is conducted with informed consent and that the privacy of those living with HIV or syphilis is strictly protected.
Epidemiological Context: HIV and Syphilis in Denmark
The statistical backdrop of Denmark’s achievement provides context for the scale of the success. Currently, Denmark maintains very low rates of HIV and syphilis among its general population, particularly among pregnant women. There are approximately 5,950 people living with HIV in Denmark, a figure that represents a small fraction of the total population. Among pregnant women, the prevalence is less than 0.1%. Through routine testing and the immediate application of treatment protocols, Denmark has effectively reduced mother-to-child transmission of HIV to zero.
The situation with syphilis follows a similar pattern of successful management. While syphilis has seen a resurgence in many parts of the developed world over the last decade, Denmark’s systematic prenatal screening has kept congenital syphilis—syphilis passed from mother to baby—extremely rare. In 2024, Denmark reported 626 cases of syphilis overall. The vast majority of these cases (524) were among men, with only 102 cases reported in women. By identifying these cases early in pregnancy, the Danish health system prevents the severe complications associated with congenital syphilis, which can include stillbirth, neonatal death, or long-term developmental issues for the child.
Official Reactions and the "Triple Elimination" Goal
For the Danish government, the WHO certification is a validation of the nation’s social contract. Sophie Løhde, Denmark’s Minister for the Interior and Health, expressed immense pride in the healthcare workforce. "This validation by WHO is a proud moment for Denmark and the result of decades of work by our health-care professionals, midwives, and public health teams to ensure that every pregnant woman receives the screening and care she needs," Løhde said. She highlighted that being the first EU country to reach this milestone carries both "honour and responsibility," expressing hope that Denmark’s experience can serve as a blueprint for other nations.
However, the work is not yet finished. Denmark is now setting its sights on "triple elimination," which involves adding hepatitis B virus (HBV) to the list of eliminated mother-to-child transmissions. Currently, the prevalence of chronic hepatitis B infection in Denmark is estimated at 0.2% to 0.3%, occurring primarily among migrant populations from endemic regions. The WHO is already collaborating with Danish authorities to advance the validation process for HBV. Reaching triple elimination would signify that a country has effectively closed the door on the three most common infections transmitted during childbirth, providing a "gold standard" of neonatal protection.
Global Context and Implications
Denmark joins a select group of 22 other countries and territories that have been validated by the WHO for the elimination of mother-to-child transmission of one or more of these infections. This diverse list includes nations such as Cuba (the first to be validated in 2015), Thailand, Malaysia, Sri Lanka, Oman, and several Caribbean nations like Antigua and Barbuda, and Saint Vincent and the Grenadines. More recently, Botswana and Namibia became the first high-burden African nations to achieve significant milestones on the path to elimination, proving that these goals are attainable across different economic and geographical landscapes.
The inclusion of Denmark is particularly significant because it demonstrates that even in highly developed regions with complex migration patterns and urbanized populations, EMTCT is sustainable. It challenges other European and North American nations to harmonize their screening protocols and data collection methods to meet WHO standards.
The implications of Denmark’s success extend beyond the immediate health of newborns. By eliminating vertical transmission, Denmark is also reducing the long-term economic burden on its healthcare system. Preventing a single case of lifelong HIV infection saves hundreds of thousands of dollars in lifetime treatment costs, not to mention the invaluable human benefit of a life lived without a chronic, stigmatized condition.
Analysis: A Model for the Future
The "Danish Model" of EMTCT offers several key lessons for the international community. First, it underscores the necessity of integrated services. In Denmark, HIV and syphilis screening are not "add-ons" but are fundamental components of standard maternal care. This integration reduces the stigma associated with testing for sexually transmitted infections (STIs).
Second, the role of midwives and primary care providers cannot be overstated. In Denmark, midwives are the primary points of contact for most pregnant women, providing a level of trust and continuity that ensures high rates of follow-up and treatment adherence.
Third, the reliance on high-quality data is paramount. Without the ability to track every mother and infant through the health system, validation would be impossible. Denmark’s investment in digital health infrastructure has paid dividends, providing the "reliable data systems" that Dr. Kluge identified as a cornerstone of the achievement.
As Denmark moves toward full triple elimination with the inclusion of hepatitis B, it continues to serve as a beacon for global health policy. The country’s experience proves that the combination of rights-based policies, high-quality clinical services, and robust data systems can turn the tide against some of the most persistent infectious diseases in human history. The WHO and the Danish government remain committed to sharing these best practices with the global community, ensuring that the goal of a generation born free of HIV, syphilis, and hepatitis B moves closer to reality for every child, regardless of where they are born.
